Venus Remedies Ltd. said its board had recommended a dividend of 30 percent or Rs.3.00 per equity share of Rs.10 each for the fiscal year 2013.
The board also approved raising of funds up to $30 million by way of equity/convertible instruments in the company/its wholly-owned subsidiary, on a preferential basis, subject to approval of the shareholders, statutory approvals, applicable laws, guidelines and regulations.
At the BSE, Venus Remedies shares are currently trading at Rs.334.50, up 0.69 percent from the previous close.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.